The cryoglobulinaemias

[1]  Y. Ubara,et al.  Hepatitis C virus-related kidney disease: various histological patterns. , 2010, Clinical nephrology.

[2]  P. Ravaud,et al.  Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry , 2010, Arthritis care & research.

[3]  M. Resche-Rigon,et al.  Surrogate markers of B cell non-Hodgkin's lymphoma in patients with hepatitis C virus-related cryoglobulinaemia vasculitis , 2010, Annals of the rheumatic diseases.

[4]  D. Sène,et al.  Presentation and outcome of gastrointestinal involvement in hepatitis C virus-related systemic vasculitis: a case–control study from a single-centre cohort of 163 patients , 2010, Gut.

[5]  G. Pasero,et al.  Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. , 2010, Arthritis and rheumatism.

[6]  J. Piette,et al.  Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. , 2010, Blood.

[7]  Felicia A Tucci,et al.  Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. , 2010, Blood.

[8]  P. Romagnoli,et al.  Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease. , 2010, Blood.

[9]  F. Gordon,et al.  Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies. , 2010, Arthritis and rheumatism.

[10]  E. Gunsilius,et al.  Bortezomib for the treatment of refractory Type‐1 cryoglobulinaemia , 2010, British journal of haematology.

[11]  Shigeto Kobayashi,et al.  EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis , 2010, Annals of the rheumatic diseases.

[12]  J. Gea-Banacloche.  Rituximab-associated infections. , 2010, Seminars in hematology.

[13]  L. Quartuccio,et al.  Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al. , 2010, Arthritis and rheumatism.

[14]  D. Landau,et al.  Causes and Predictive Factors of Mortality in a Cohort of Patients with Hepatitis C Virus-related Cryoglobulinemic Vasculitis Treated with Antiviral Therapy , 2010, The Journal of Rheumatology.

[15]  S. Salvadori,et al.  Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus , 2010, Scandinavian journal of rheumatology.

[16]  W. Egner,et al.  Cryoglobulin evaluation: best practice? , 2010, Annals of clinical biochemistry.

[17]  Jean-Michel Pawlotsky,et al.  Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. , 2009, The New England journal of medicine.

[18]  Z. Amoura,et al.  Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis. , 2009, Arthritis and rheumatism.

[19]  F. Roudot-thoraval,et al.  Clinical and Morphologic Spectrum of Renal Involvement in Patients With Mixed Cryoglobulinemia Without Evidence of Hepatitis C Virus Infection , 2009, Medicine.

[20]  Felicia A Tucci,et al.  Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular Damage1 , 2009, The Journal of Immunology.

[21]  I. Dahabreh,et al.  Hematologic Manifestations and Predictors of Lymphoma Development in Primary Sjögren Syndrome: Clinical and Pathophysiologic Aspects , 2009, Medicine.

[22]  S. Treon.  How I treat Waldenström macroglobulinemia. , 2009, Blood.

[23]  M. Ghany,et al.  Diagnosis, management, and treatment of hepatitis C: An update , 2009, Hepatology.

[24]  M. Fiscella,et al.  Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  L. Fink,et al.  Response to bortezomib in refractory type I cryoglobulinemia , 2008, American journal of hematology.

[26]  C. Ferri,et al.  Mixed cryoglobulinemia , 2008, Orphanet journal of rare diseases.

[27]  D. Landau,et al.  Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis. , 2008, Blood.

[28]  C. Alpers,et al.  Cryoglobulinemia and renal disease , 2008, Current opinion in nephrology and hypertension.

[29]  D. Landau,et al.  Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. , 2008, Arthritis and rheumatism.

[30]  C. Rice,et al.  Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. , 2008, Blood.

[31]  J. Piette,et al.  Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis , 2008, Current Opinion in Rheumatology.

[32]  B. Bacon,et al.  Phase 1B, randomized, double‐blind, dose‐escalation trial of CPG 10101 in patients with chronic hepatitis C virus , 2007, Hepatology.

[33]  C. Beltrami,et al.  Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis. , 2007, Rheumatology.

[34]  D. Sansonno,et al.  Mixed cryoglobulinemia: a model of virus-related disease in internal medicine. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[35]  G. Monti,et al.  Emergency in cryoglobulinemic syndrome: what to do? , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[36]  G. Monti,et al.  Causes of death in symptomatic cryoglobulinemia: 30 years of observation in a Department of Internal Medicine. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[37]  S. Pileri,et al.  HCV-related autoimmune and neoplastic disorders: the HCV syndrome. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[38]  D. Landau,et al.  Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. , 2007, Rheumatology.

[39]  M. Ramos-Casals,et al.  Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors. , 2007, Rheumatology.

[40]  Sanjeev Arora,et al.  Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study. , 2007, Journal of hepatology.

[41]  H. El‐Serag,et al.  Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. , 2007, JAMA.

[42]  E. Heathcote,et al.  Symptomatic and Virological Response to Antiviral Therapy in Hepatitis C Associated with Extrahepatic Complications of Cryoglobulimia , 2007, Digestive Diseases and Sciences.

[43]  J. Yagüe,et al.  Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases. , 2006, Seminars in arthritis and rheumatism.

[44]  L. Rostaing,et al.  Life-threatening infections following rituximab therapy in renal transplant patients with mixed cryoglobulinemia. , 2006, Clinical nephrology.

[45]  J. Piette,et al.  Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study. , 2006, Arthritis and rheumatism.

[46]  J. Piette,et al.  Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. , 2006, Archives of internal medicine.

[47]  D. Sansonno,et al.  Hepatitis C virus infection, cryoglobulinaemia, and beyond. , 2006, Rheumatology.

[48]  G. Panayiotakopoulos,et al.  Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV‐positive, HCV‐negative patients , 2006, Journal of medical virology.

[49]  A. Bryce,et al.  Natural history and therapy of 66 patients with mixed cryoglobulinemia , 2006, American journal of hematology.

[50]  L. Quartuccio,et al.  Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. , 2006, Rheumatology.

[51]  E. Beghi,et al.  Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[52]  C. Ferri,et al.  Cryoglobulinemic vasculitis , 2006, Current opinion in rheumatology.

[53]  M. Houghton,et al.  Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Y. Naparstek,et al.  Alveolar hemorrhage in cryoglobulinemia--an indicator of poor prognosis. , 2005, Clinical and experimental rheumatology.

[55]  J. Hoofnagle,et al.  Mechanism of action of interferon and ribavirin in treatment of hepatitis C , 2005, Nature.

[56]  D. Sansonno,et al.  Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. , 2005, The Lancet. Infectious diseases.

[57]  J. Piette,et al.  PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. , 2005, Arthritis and rheumatism.

[58]  S. Morgello.  The nervous system and hepatitis C virus. , 2005, Seminars in liver disease.

[59]  A. Gabrielli,et al.  Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. , 2005, Archives of internal medicine.

[60]  M. Ramos-Casals,et al.  Mycophenolate mofetil in patients with hepatitis C virus infection , 2005, Lupus.

[61]  G. Mazzucco,et al.  Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[62]  J. Piette,et al.  Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus. , 2004, The Journal of rheumatology.

[63]  E. Ferrannini,et al.  Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. , 2004, QJM : monthly journal of the Association of Physicians.

[64]  M. Wener,et al.  Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. , 2004, Arthritis and rheumatism.

[65]  Claudio Michelassi,et al.  Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. , 2004, Seminars in arthritis and rheumatism.

[66]  P. Marcellin,et al.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. , 2004, Annals of internal medicine.

[67]  A. López-Guillermo,et al.  Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma. , 2004, The Journal of rheumatology.

[68]  Felicia A Tucci,et al.  Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection , 2004, European journal of immunology.

[69]  W. Solbach,et al.  Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis , 2003, Annals of the rheumatic diseases.

[70]  C. Scagnolari,et al.  Occult hepatitis C virus infection in type II mixed cryoglobulinaemia , 2003, Journal of viral hepatitis.

[71]  S. Bombardieri,et al.  Hyperviscosity syndrome in cryoglobulinemia: clinical aspects and therapeutic considerations. , 2003, Seminars in thrombosis and hemostasis.

[72]  R. Barale,et al.  Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. , 2003, Rheumatology.

[73]  R. Nemni,et al.  Pubcrawler: www.pubcrawler.ie , 2003, Journal of neurology, neurosurgery, and psychiatry.

[74]  D. Sansonno,et al.  Non‐enveloped HCV core protein as constitutive antigen of cold‐precipitable immune complexes in type II mixed cryoglobulinaemia , 2003, Clinical and experimental immunology.

[75]  A. López-Guillermo,et al.  Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases. , 2003, Seminars in arthritis and rheumatism.

[76]  J. Piette,et al.  Hepatitis C virus infection in systemic lupus erythematosus: a case-control study. , 2003, The Journal of rheumatology.

[77]  Felicia A Tucci,et al.  Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. , 2003, Blood.

[78]  R. Fanin,et al.  Efficacy and safety of rituximab in type II mixed cryoglobulinemia. , 2003, Blood.

[79]  M. Russo,et al.  Side effects of therapy for chronic hepatitis C. , 2003, Gastroenterology.

[80]  R. Torella,et al.  Prevalence and Incidence of Cryoglobulins in Hepatitis C Virus–Related Chronic Hepatitis Patients: A Prospective Study , 2003, American Journal of Gastroenterology.

[81]  A. Bakker,et al.  Adequate Sampling in Cryoglobulinaemia: Recommended Warmly , 2003, Clinical chemistry and laboratory medicine.

[82]  B. Zimmerman,et al.  Hepatitis C, cryoglobulinemia, and cirrhosis: A meta‐analysis , 2002, Hepatology.

[83]  John P. Johnson,et al.  The Clinical and Morphologic Spectrum of Renal Cryoglobulinemia , 2002, Medicine.

[84]  P. Cacoub,et al.  Fatigue in patients with chronic hepatitis C , 2002, Journal of viral hepatitis.

[85]  L. Mouthon,et al.  Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia. , 2002, Rheumatology.

[86]  G. Melli,et al.  Cryoglobulinemia is a frequent cause of peripheral neuropathy in undiagnosed referral patients , 2002, Journal of the peripheral nervous system : JPNS.

[87]  D. Vassilopoulos,et al.  Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies. , 2002, Arthritis and rheumatism.

[88]  T. Ahuja,et al.  Prevalence of Glomerulopathies in Autopsies of Patients Infected with the Hepatitis C Virus , 2001, The American journal of the medical sciences.

[89]  J. Yagüe,et al.  Cryoglobulinemia: Study of Etiologic Factors and Clinical and Immunologic Features in 443 Patients from a Single Center , 2001, Medicine.

[90]  M. Matsushita,et al.  Role of galactosylation in the renal pathogenicity of murine immunoglobulin G3 monoclonal cryoglobulins. , 2001, Blood.

[91]  J. Yagüe,et al.  Cryoglobulinemia in systemic lupus erythematosus: prevalence and clinical characteristics in a series of 122 patients. , 2001, Seminars in arthritis and rheumatism.

[92]  Josep Maria Salanova Grau,et al.  Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity. , 1999, Arthritis and rheumatism.

[93]  A. Hatzakis,et al.  Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. , 1999 .

[94]  M. Houghton,et al.  Binding of hepatitis C virus to CD81. , 1998, Science.

[95]  G. D'Amico,et al.  Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. , 1998, Kidney international.

[96]  R. Finch,et al.  Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia. , 1998, The Journal of infection.

[97]  M. Trendelenburg,et al.  Cryoglobulins are not essential , 1998, Annals of the rheumatic diseases.

[98]  D. Roulot,et al.  Prevalence of cryoglobulins and hepatitis C virus infection in HIV-infected patients. , 1997, Clinical and experimental rheumatology.

[99]  D. Sansonno,et al.  Hepatitis C virus‐related proteins in kidney tissue from hepatitis C virus‐infected patients with cryoglobulinemic membranoproliferative glomerulonephritis , 1997, Hepatology.

[100]  Y. Ilan,et al.  Hepatitis C-associated cryoglobulinemia presenting with pericardial effusion. , 1997, The American journal of gastroenterology.

[101]  A. Tzioufas,et al.  Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. , 1996, Arthritis and rheumatism.

[102]  G. Pasero,et al.  Mixed cryoglobulinemia as a possible preneoplastic disorder. , 1995, Arthritis and rheumatism.

[103]  G. Monti,et al.  The natural history of cryoglobulinemia: symptoms at onset and during follow-up. A report by the Italian Group for the Study of Cryoglobulinemias (GISC) , 1995, Clinical and experimental rheumatology.

[104]  A. Gabrielli,et al.  GISC protocol experience in the treatment of essential mixed cryoglobulinaemia. , 1995, Clinical and experimental rheumatology.

[105]  D. Sansonno,et al.  Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus–infected patients with mixed cryoglobulinemia , 1995, Hepatology.

[106]  G. D'Amico,et al.  Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. , 1995, Kidney international.

[107]  H. Bonkovsky,et al.  Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage , 1995 .

[108]  S. Bombardieri,et al.  Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed cryoglobulinaemia. , 1994, British journal of rheumatology.

[109]  J. Vázquez,et al.  Association between hepatitis C virus and mixed cryoglobulinemia. , 1991, Reviews of infectious diseases.

[110]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[111]  J. Vallat,et al.  Cryoglobulinemic neuropathy: A pathological study , 1980, Annals of neurology.

[112]  J. Clauvel,et al.  Biologic and clinical significance of cryoglobulins. A report of 86 cases. , 1974, The American journal of medicine.

[113]  A. Lerner,et al.  STUDIES OF CRYOGLOBULINS. I. UNUSUAL PURPURA ASSOCIATED WITH THE PRESENCE OF A HIGH CONCENTRATION OF CRYOGLOBULIN (COLD PRECIPITABLE SERUM GLOBULIN) , 1947, The American journal of the medical sciences.

[114]  C. F. Geschickter,et al.  HYPERPROTEINEMIA ASSOCIATED WITH MULTIPLE MYELOMAS: REPORT OF AN UNUSUAL CASE , 1928 .

[115]  X. Bosch,et al.  Life-Threatening Cryoglobulinemia , 2011 .

[116]  T. Maisonobe,et al.  [Cryoglobulinemic peripheral neuropathy in hepatitis C virus infection: clinical and anatomical correlations of 22 cases]. , 2010, Revue neurologique.

[117]  P. Vermeersch,et al.  A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins. , 2008, Clinical chemistry.

[118]  D. Sène,et al.  Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF). , 2007, Rheumatology.

[119]  A. Amoroso,et al.  Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[120]  Pojen P. Chen,et al.  Cross-reacting idiotypes on cryoprecipitating rheumatoid factor , 2005, Springer Seminars in Immunopathology.

[121]  A. Tzioufas,et al.  Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. , 2005, Autoimmunity reviews.

[122]  Y. Jeong,et al.  Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection , 2003 .

[123]  M. Cid,et al.  [Tetraparesis and paresthesias in the lower extremities in a 58-year-old man]. , 1999, Medicina clinica.

[124]  R. Tait,et al.  The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma--a regional association? , 1997, Leukemia & lymphoma.

[125]  Z. Shihabi.  Analysis and general classification of serum cryoglobulins by capillary zone electrophoresis , 1996, Electrophoresis.

[126]  L. Adinolfi,et al.  Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study. , 1996, The Italian journal of gastroenterology.

[127]  P. Caramaschi,et al.  Cryoglobulinaemia and hepatitis C virus (HCV) infection. , 1991, Clinical and experimental rheumatology.

[128]  P. Lambert,et al.  The presence of cryoprecipitable immunoglobulins in normal human sera may reflect specific molecular interactions. , 1989, Autoimmunity.

[129]  O. Lantz,et al.  Recurrent essential mixed cryoglobulinemia in renal allografts. Report of two cases and review of the literature. , 1989, American journal of nephrology.

[130]  J. Vallat,et al.  Cryoglobulinemic neuropathy: ultrastructural study of the nerve capillaries. , 1981, Acta neuropathologica. Supplementum.